Aagylur Capsule
Product Images NDC 70709-102

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Aagylur (NDC 70709-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cycle Pharmaceuticals Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Formula)

Chemical structure diagram depicting the specific optical rotation parameters of Penicillamine in solution (1N NaOH), as indicated by the alpha value at 25 degrees Celsius.*

FDA Label Image

Structure (Structure)

Chemical structure of penicillamine, showing its molecular arrangement with amino, thiol, carboxyl, and methyl groups.*

FDA Label Image

Fig1 (Figure1)

A chemical reaction diagram illustrating thiol-disulfide exchange between cysteine species. It shows equilibria between CSSC + PS- and CS + CSSP, between PSSP + CS and PS- + CSSP, and between CSSC + PSSP- and 2CSSP species.*

FDA Label Image

Container Label (Label)

AAGYLUR (penicillamine) Capsules, USP 250 mg label for a 100-capsule container. The label includes dosage strength, prescription status (Rx only), manufacturer information (Cycle Pharmaceuticals Ltd., UK), storage instructions, and a barcode with NDC 70709-102.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.